Trading by management and close relations of management

In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the “Market Abuse Regulation”) and commission delegated regulation (EU) 1052/2016
of 8 March 2016, Novonesis reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B.

Please read the full announcement in PDF.

Attachment

• 2026_08_Trading_By_Management

You May Also Be Interested In

• Xos Extends Gross Profit Streak, Highlighting Operational Efficiency
• MacroGenics Reports Second Quarter 2026 Financial Results, Streamlined Operating Model and Strengthened Financial Position
• Rani Therapeutics Reports Second Quarter 2026 Financial Results; Provides Corporate Update